Upper Esophageal Sphincter
Conditions
Keywords
Upper Esophageal Sphincter, botulinum toxin, Cricopharyngeal dysfunction, Cricopharyngeal botulinum toxin injection
Brief summary
The objective of the study, after reviewing the recent literature, is to corroborate the thesis of the authors considering the injection of botulinum toxin as a gesture that is both diagnostic and therapeutic in the disorders of the Upper Esophageal Sphincter and reinforce the results already published with a larger series of patients.
Interventions
None listed
Sponsors
University Hospital, Strasbourg, France
Study design
Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* Man or woman whose age older than 18 years * Dysphagia with solids and / or liquids * Dysfunction of primary or secondary Upper Esophageal Sphincter with indirect video-fibroscopy and / or video-fluoroscopy and / or high resolution pharyngo-oesophageal manometry * Subject having at least one injection of botulinum toxin A in the crico-pharyngeal muscle for Upper Esophageal Sphincter dysfunction in the ENT department and cervico-facial surgery of Hautepierre. * Subject who has consented to the use of his data from his medical file for the purpose of this research
Exclusion criteria
* Myotomy in the first place * Refusal of the subject to participate in the study * Subject under the protection of justice * Subject under guardianship or curatorship
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Deglutition Handicap Index | The period from January 1st, 2017 to December 31st, 2017 will be examined |
Countries
France
Contacts
Primary ContactPhilippe Schultz, MD, PhD
Backup ContactSophie Gorostis, MD
Outcome results
None listed